Clinical trial Recruiting at 2 sites Phase 2 Interventional Ages 18 to 25

Accelerating tooth movement with MOP, prostaglandin E1, and calcitriol

Official title: A Comparative Clinical Evaluation of the Mini-Implant Facilitated Micro-Osteoperforation (MOP), Prostaglandin E1 and Calcitriol Injections in Accelerating of Orthodontic Tooth Movement: Randomized Controlled Clinical Trial

Run by University of Baghdad · NCT07842120 · Data updated 2026-11-12

This study tests whether micro-osteoperforations, prostaglandin E1 injections, or calcitriol injections can speed up orthodontic tooth movement in young adults with moderate lower-front crowding.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 25 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Baghdad
Academic / other
Locations2 sites (Baghdad, Baghdad Governorate and 1 other locations)
StatusRecruiting
StartedApril 16, 2026
Main results expectedDecember 30, 2026
Study endsFebruary 2027
Registry record updatedSeptember 25, 2026
Trial IDNCT07842120 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 18-25 years old with moderate mandibular anterior crowding (LII 4-6 mm), requiring non-extraction fixed appliances, and good periodontal health.

Probably not a fit

Patients with systemic or bone/metabolic disorders, recent orthodontic history, or allergies to study agents may not benefit and could be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 2 trial compares three interventions—micro-osteoperforation, prostaglandin E1 injections, and calcitriol injections—to see if they can accelerate the rate of orthodontic tooth movement in adults aged 18 to 25 receiving fixed appliances for non-extractive treatment. Participants are healthy in terms of periodontal status and must have a specific crowding range in the lower front teeth. The study uses local administration of the agents or surgical stimulation as adjuncts to standard orthodontic care, with safety and movement rate as key outcomes. The trial is conducted at two units within the College of Dentistry, University of Baghdad, under the lead sponsorship of Ghufran Dhari Awad.

Why it matters

Potential benefit: If successful, the approach could shorten orthodontic treatment time for eligible patients.

How similar studies have gone: There has been prior exploration of local agents and surgical methods to accelerate tooth movement, with mixed results; this study contributes additional evidence in a focused population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient age 18-25.

  * Patient with moderate crowding in mandibular anterior region with Little Irrigularity Index (LII) 4-6 mm.
  * Indicated for fixed orthodontic appliance therapy (non-extraction treatment)
  * Healthy periodontium (probing depths ≤3 mm, gingival and plaque indices6 scores ≤ 1, bleeding on probing ≤ 10%).
  * Presence of all the mandibular permanent teeth, except the third molars.
  * The overbite and overjet should not impede bracket placement on the mandibular anterior teeth.

Exclusion Criteria:

Systemic diseases affecting bone (osteoporosis, endocrine disorders), kidney disease, hyperparathyroidism.

* Medications affecting bone metabolism (bisphosphonates, systemic steroids, Vitamin D3 supplements).
* Known allergy to study agents or local anesthetics.
* History of previous orthodontic intervention
* History of trauma or root resorption in the mandibular anterior teeth

Where it's running

  • College of Dentistry, University of Baghdad
    Baghdad, Baghdad Governorate, Iraq
    Recruiting
  • College of Dentistry, University of Baghdad
    Baghdad, Baghdad Governorate, Iraq
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.